N-SIDE services

By optimizing manufacturing for the entire clinical program and optimizing supply for each individual trial, we can typically free up to 50% of the initially planned quantities and accelerate time to commercialization by 2-6 months. We accomplish this by reducing drug needs at the trial level and limiting manufacturing waste. That enables us to either cancel production lots and re-allocate the resources to new programs, or to re-invest that drug into increased sites and recruitment speed.

Transitioning to a digital, data-driven clinical supply chain requires more than technology; it demands adaptation throughout the business. N-SIDE experts will support your change management journey, starting with a clear vision associated with measurable added value for R&D efficiency. Keeping this purpose in mind, N-SIDE will help your teams take advantage of advanced analytics to become a truly data-driven organization.